Homeopathy as adjuvant to standard treatment protocol in management of corona virus infection- a randomized, placebo controlled, open label study

Central Council for Research in Homeopathy Ministry Ministry of Ayush0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. Age > 18 years
•2. All sexes
•3. Case definitions for inclusion in the study will include moderate and severe cases as defined in the Guidance on appropriate treatment of suspect/confirmed case of COVID19 issued by Ministry of Health and Family Welfare, Govt of India on 07 Apr 2020.
•a. Moderate: Pneumonia with no signs of severe disease (Respiratory Rate 15 to 30/minute, SpO2 90%-94%).
•b. Severe: Severe Pneumonia (with respiratory rate < 30/minute and/or SpO2 and requiring non-invasive ventilatory support
•4. Laboratory confirmed SARS CoV-2 infection within last 10 days or SARS
•5. CoV-2 test result pending with a high clinical suspicion as defined by:
•a. Cough of <10d duration
•b. Bilateral pulmonary infiltrates on chest X Ray / CT scan or new hypoxaemia defined as SpO2 <94% on room air
•c. No alternative explanation for respiratory symptoms
•d. Scheduled for admission or enrolled within 48h of hospital admission

•1. Children < 18 years
•2. Covid Positive patients with severe co-morbidities
•3. Pregnant and lactating women, infants and neonates
•4. Not willing to give consent for adjuvant treatment
•5. Inability to be contacted on D14 for clinical outcome assessment (unless died in hospital)
•6. In the opinion of the clinical team, progression to death is imminent and inevitable within the next 24 hours, irrespective of the provision of treatments.
•7. Symptoms of acute respiratory tract infection for > 10d before randomisation, and covid status unknown
•8. Death within 24 Hrs. of admission

发起方

Central Council for Research in Homeopathy Ministry Ministry of Ayush